CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹4,122 Cr | ₹2,802 Cr | ₹2,517 Cr | ₹2,405 Cr | ₹1,547 Cr |
What is the latest Consolidated Net Profit of CIPLA ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹4,122 Cr |
Mar2024 | ₹2,802 Cr |
Mar2023 | ₹2,517 Cr |
Mar2022 | ₹2,405 Cr |
Mar2021 | ₹1,547 Cr |
How is Consolidated Net Profit of CIPLA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹4,122 Cr | 47.10 | |
Mar2024 | ₹2,802 Cr | 11.33 | |
Mar2023 | ₹2,517 Cr | 4.65 | |
Mar2022 | ₹2,405 Cr | 55.50 | |
Mar2021 | ₹1,547 Cr | - |
Compare Consolidated Net Profit of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹123,682.3 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
MANKIND PHARMA | ₹107,363.0 Cr | -1.7% | 13% | 22.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 3.8% |
1.2% |
-1.1% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses